Sun-Taro issue nears end
The saga of Sun Pharma's protracted battle to acquire control of Israel's Taro Pharma seems to be approaching its final hours. Sun, in a last ditch attempt at an early resolution has proposed two options. The first involves a 22 per cent premium to its earlier offer, which will cost Sun $45 million or more.
![Gadgets 360 With Technical Guruji: Did You Know? [October 5, 2024]](https://c.ndtvimg.com/2024-10/khm6ijp8_did-you-know_160x120_05_October_24.jpg?downsize=355∶533 "Gadgets 360 With Technical Guruji: Did You Know? [October 5, 2024]")
![Gadgets 360 With Technical Guruji: News of the Week [October 5, 2024]](https://c.ndtvimg.com/2024-10/jgj2u8h_news-of-the-week_160x120_05_October_24.jpg?downsize=355∶533 "Gadgets 360 With Technical Guruji: News of the Week [October 5, 2024]")
